As we continue our journey with the philosophy of “People first, health first” from past to present, the support we have received from our physicians
has motivated us to invest more in R&D and to produce more domestic products. As of April 2026, we are increasing our active product portfolio in the field of women’s health from 14 to 17.
With these three unique products, which will be launched soon, we continue to grow by saying “More treatment options, more support for treatment options, and more health.”